TCM
ANAB icon

Tang Capital Management’s AnaptysBio ANAB Stock Holding History

Tang Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.8M Hold
1,330,879
– – 4.08% 12
2026
Q1 		$73.8M Sell
1,330,879
-1,208
-0.1% -$65K 3.75% 14
2025
Q4 		$64.6M Sell
1,332,087
-1,552
-0.1% -$60.5K 3.19% 12
2025
Q3 		$40.8M Buy
1,333,639
+2,760
+0.2% +$63.3K 1.57% 16
2025
Q2 		$29.5M Sell
1,330,879
-214,274
-14% -$4.49M 1.49% 18
2025
Q1 		$28.7M Buy
1,545,153
+214,274
+16% +$3.57M 1.59% 14
2024
Q4 		$17.6M Hold
1,330,879
– – 1.17% 21
2024
Q3 		$44.6M Hold
1,330,879
– – 3.18% 7
2024
Q2 		$33.4M Hold
1,330,879
– – 3.4% 5
2024
Q1 		$30M Sell
1,330,879
-619,730
-32% -$14.7M 3.12% 4
2023
Q4 		$41.8M Hold
1,950,609
– – 3.86% 6
2023
Q3 		$35M Hold
1,950,609
– – 4.94% 3
2023
Q2 		$39.7M Sell
1,950,609
-81,952
-4% -$1.66M 5.84% 1
2023
Q1 		$44.2M Sell
2,032,561
-596,117
-23% -$14.5M 6.59% 1
2022
Q4 		$81.5M Hold
2,628,678
– – 11.84% 1
2022
Q3 		$67.1M Hold
2,628,678
– – 8.22% 1
2022
Q2 		$53.4M Hold
2,628,678
– – 8.1% 1
2022
Q1 		$65M Hold
2,628,678
– – 13.01% 1
2021
Q4 		$91.3M Hold
2,628,678
– – 18.37% 1
2021
Q3 		$71.3M Hold
2,628,678
– – 14.8% 3
2021
Q2 		$68.2M Hold
2,628,678
– – 13.57% 3
2021
Q1 		$56.6M Hold
2,628,678
– – 15.94% 2
2020
Q4 		$56.5M Hold
2,628,678
– – 8.63% 4
2020
Q3 		$38.8M Buy
2,628,678
+100,000
+4% +$1.8M 7.02% 5
2020
Q2 		$56.5M Buy
2,528,678
+237,851
+10% +$4.35M 5.49% 4
2020
Q1 		$32.4M Buy
2,290,827
+447,013
+24% +$6.78M 4.55% 6
2019
Q4 		$30M Buy
+1,843,814
New +$43.6M 3.58% 6

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tang Capital Management's ANAB Position: Q2 2026 in Review

Tang Capital Management held its AnaptysBio (ANAB) position steady in Q2 2026 at 1,330,879 shares worth $89.8M. The position accounts for 4.08% of the portfolio, ranked #12.

Tang Capital Management first reported a position in ANAB in Q4 2019 and has held it in 27 quarters since. The position peaked at $91.3M in Q4 2021. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Tang Capital Management held 1,330,879 shares of AnaptysBio worth $89.8M as of Q2 2026.
  • Tang Capital Management left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up 4.08% of Tang Capital Management's portfolio in Q2 2026, its #12 holding.
  • Tang Capital Management first reported a position in AnaptysBio in Q4 2019 and has held it in 27 quarters since.
  • Tang Capital Management's AnaptysBio position peaked at $91.3M in Q4 2021.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.